Advocates for Universal DPD/DPYD Testing

Advocates for Universal DPD/DPYD Testing

Our mission is simple and urgent: to make pretreatment DPYD genetic testing the standard of care. Advocates for Universal DPD/DPYD Testing (AUDT) is committed to protecting cancer patients from preventable harm caused by fluoropyrimidine chemotherapy drugs such as 5-fluorouracil (5-FU) and capecitabine (Xeloda). These widely prescribed treatments can be life-threatening for patients with dihydropyrimidine dehydrogenase (DPD) deficiency, a genetic condition that impairs the body’s ability to break down these drugs.

Yes